北京轩升制药

Beijing Xuansheng Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and commercialization of high-end generic and innovative drugs. The company specializes in therapeutic areas such as cardiovascular and cerebrovascular diseases, the central nervous system, and metabolic disorders. Xuansheng operates a comprehensive platform that integrates R&D with large-scale manufacturing capabilities, including GMP-certified facilities in Beijing. Their product portfolio includes treatments for acute ischemic stroke and anticoagulants, aiming to provide high-quality, affordable medical solutions to the Chinese market. The firm is recognized as a high-tech enterprise and is committed to meeting international quality standards through rigorous consistency evaluations.